Gene · 9
Papers1,709
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
21 to 40 of 1,709
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Mini-review: Human N-acetyltransferase genetic polymorphisms in susceptibility to aromatic amine and alkylaniline genotoxicity. | J Pharmacol Exp Ther | 2025 | 40834652 | PubTator, text mining | PubMed |
| Altered Levels of miRNA-1290 and lncRNA-H19 in Exosomes of Patients Recently Diagnosed With Acute Lymphoblastic Leukemia. | In Vivo | 2025 | 40579001 | PubTator, text mining | PubMed |
| Leveraging long-read sequencing technologies for pharmacogenomic testing: applications, analytical strategies, challenges, and future perspectives. | Front Genet | 2025 | 40370700 | PubTator, text mining | PubMed |
| Investigating the mechanisms by which low NAT1 expression in tumor cells contributes to chemo-resistance in colorectal cancer. | Clin Epigenetics | 2025 | 40329330 | PubTator, text mining | PubMed |
| Challenges in Predicting Colonic Luminal and Tissue Concentrations of Mesalamine and Acetyl Mesalamine using Physiologically Based Biopharmaceutics Modeling. | Int J Pharm | 2025 | 40174807 | PubTator, text mining | PubMed |
| Multi-omics approach reveals the impact of prognosis model-related genes on the tumor microenvironment in medulloblastoma. | Front Oncol | 2025 | 40104502 | PubTator, text mining | PubMed |
| Arylamine N-acetyltransferase 1 expression predicts glucose dependence and mitochondrial bioenergetics in cancer cells. | Biochim Biophys Acta Mol Cell Res | 2025 | 40054776 | PubTator, text mining | PubMed |
| Variability in intestinal drug metabolizing enzymes and transporters in Crohn's disease and potential impact on oral drug absorption. | Br J Clin Pharmacol | 2025 | 40040248 | PubTator, text mining | PubMed |
| ESCO1 as a novel predictive biomarker and potential therapeutic target in renal cell carcinoma. | Tumori | 2025 | 39956919 | PubTator, text mining | PubMed |
| HPV E6/E7-Induced Acetylation of a Peptide Encoded by a Long Non-Coding RNA Inhibits Ferroptosis to Promote the Malignancy of Cervical Cancer. | Adv Sci (Weinh) | 2025 | 39836502 | PubTator, text mining | PubMed |
| Characterization of NAT, GST, and CYP2E1 Genetic Variation in Sub-Saharan African Populations: Implications for Treatment of Tuberculosis and Other Diseases. | Clin Pharmacol Ther | 2025 | 39829327 | PubTator, text mining | PubMed |
| Enhancement of detoxification of xenobiotic aromatic amine dyes by N-acetyltransferase 1 (NAT1) enzyme on human keratinocytes cells through structural modification. | Environ Toxicol Pharmacol | 2025 | 39725341 | PubTator, text mining | PubMed |
| Arylamines N-acetyltransferases 1 and 2: physiology, genetics and epigenetics. | Gac Med Mex | 2024 | 40000435 | PubTator, text mining | PubMed |
| Bioactivation, Mutagenicity, DNA Damage, and Oxidative Stress Induced by 3,4-Dimethylaniline. | Biomolecules | 2024 | 39766269 | PubTator, text mining | PubMed |
| A pan-cancer analysis of the oncogenic role of N-acetyltransferase 8 like in human cancer. | Discov Oncol | 2024 | 39692770 | PubTator, text mining | PubMed |
| Identification of key programmed cell death genes for predicting prognosis and treatment sensitivity in colorectal cancer. | Front Oncol | 2024 | 39610918 | PubTator, text mining | PubMed |
| Integrative Analysis of ATAC-Seq and RNA-Seq through Machine Learning Identifies 10 Signature Genes for Breast Cancer Intrinsic Subtypes. | Biology (Basel) | 2024 | 39452108 | PubTator, text mining | PubMed |
| Neoadjuvant sunitinib plus exemestane in post-menopausal women with hormone receptor-positive/HER2-negative early-stage breast cancer (SUT_EXE-08): a phase I/II trial. | Sci Rep | 2024 | 39384801 | PubTator, text mining | PubMed |
| Complete mitochondrial genome sequence of the white root rot pathogen Dematophora necatrix (Xylariaceae: Xylariales). | Mitochondrial DNA B Resour | 2024 | 39286473 | PubTator, text mining | PubMed |
| LSD1 inhibits the invasion and migration of breast cancer through exosomes. | Sci Rep | 2024 | 39242625 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9/papers?page=2